Mr. von Rickenbach is Chairman, Chief Executive Officer, and Co-Founder of PAREXEL International Corporation, a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Under Mr. von Rickenbach’s leadership, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL operates in 56 locations throughout 43 countries around the world, and has over 6,215 employees.

Prior to founding PAREXEL, Mr. von Rickenbach was employed by ENSECO (formerly ERCO), as the Manager of European Operations. He began his career at Schering-Plough, Inc. in Lucerne, Switzerland.

Mr. von Rickenbach presents regularly at North American and European investor and industry conferences, and pharmaceutical and other professional industry meetings. He was awarded the Ernst & Young 1997 New England Region Entrepreneur of the Year.

Mr. von Rickenbach holds a Bachelor of Business Administration from the Lucerne College of Industrial Economics and Administration in Switzerland and received his Masters of Business Administration from the Harvard University Graduate School of Business Administration.